Novel emm4 lineage associated with an upsurge in invasive group A streptococcal disease in the Netherlands, 2022
B. C. van der Putten, W. C. Bril-Keijzers, L. W. Rumke, S. M. T. Vestjens, L. A. Koster, M. Willemsen, M. A. van Houten, N. Y. Rots, B. J. M. Vlaminckx, B. de Gier, N. M. van Sorge
The paper identifies a novel emm4 lineage, M4NL22, as the cause of an increase in invasive group A streptococcal disease in the Netherlands in 2022.
bioRxiv · Dec 31, 2022 · PreprintMicrobiology